While tirzepatide does not directly cause sweating through its pharmacological action, several mechanisms may explain why patients experience increased perspiration during treatment: Hypoglycemia is the most clinically significant cause of sweating in patients taking tirzepatide, particularly when combined with insulin or sulfonylureas
(This also explains why aqueous-solubility models outperformed intrinsic-solubility models on the intrinsic-solubility test sets.) Nevertheless, using to predict pH-dependent solubility gives a good qualitative match with experiment, excepting cases where ion aggregation leads to lower-than-expected solubility
When semaglutide GLP-1 binds to the GLP-1 receptors in the brain, it amplifies the activity of these receptors, leading to a series of metabolic effects beneficial for weight management
Cell Mol Life Sci 68:22012213
Collagen's Role in Skin Structure and Firmness Collagen is essential for preserving the strength, structure, and rigidity of the skin
Taken together, this is the first study to describe the hepatic metabolome after ischemic AKI in a murine model and demonstrates that there is significant liver-kidney crosstalk after AKI